Asset Management
Compare Stocks
4 / 10Stock Comparison
SAR vs CSWC vs ARCC vs GAIN
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management
Asset Management
Asset Management
SAR vs CSWC vs ARCC vs GAIN — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Asset Management | Asset Management | Asset Management | Asset Management |
| Market Cap | $363M | $1.43B | $13.61B | $657M |
| Revenue (TTM) | $125.71B | $164M | $3.15B | $90M |
| Net Income (TTM) | $39M | $103M | $1.15B | $130M |
| Gross Margin | — | 66.5% | 75.7% | 68.6% |
| Operating Margin | -0.1% | 48.5% | 69.7% | 72.7% |
| Forward P/E | 9.0x | 10.1x | 9.9x | 40.7x |
| Total Debt | $293.33B | $956M | $15.99B | $456M |
| Cash & Equiv. | $22.32B | $43M | $924M | $14M |
SAR vs CSWC vs ARCC vs GAIN — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Saratoga Investment… (SAR) | 100 | 147.2 | +47.2% |
| Capital Southwest C… (CSWC) | 100 | 171.6 | +71.6% |
| Ares Capital Corpor… (ARCC) | 100 | 128.5 | +28.5% |
| Gladstone Investmen… (GAIN) | 100 | 148.9 | +48.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SAR vs CSWC vs ARCC vs GAIN
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SAR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 5 yrs, beta 0.60, yield 100.0%
- Rev growth 1.3K%, EPS growth 14.4%
- PEG 0.76 vs ARCC's 0.96
- 1.3K% NII/revenue growth vs GAIN's -12.9%
CSWC is the clearest fit if your priority is bank quality.
- NIM 7.0% vs ARCC's 3.6%
- +34.0% vs ARCC's +0.4%
ARCC is the #2 pick in this set and the best alternative if quality and efficiency is your priority.
- Efficiency ratio 0.1% vs SAR's 0.7% (lower = leaner)
- Efficiency ratio 0.1% vs SAR's 0.7%
GAIN is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 319.3% 10Y total return vs CSWC's 234.2%
- Lower volatility, beta 0.53, Low D/E 91.3%, current ratio 3.69x
- Beta 0.53, yield 10.0%, current ratio 3.69x
- Beta 0.53 vs CSWC's 0.84, lower leverage
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.3K% NII/revenue growth vs GAIN's -12.9% | |
| Value | Lower P/E (9.0x vs 10.1x) | |
| Quality / Margins | Efficiency ratio 0.1% vs SAR's 0.7% (lower = leaner) | |
| Stability / Safety | Beta 0.53 vs CSWC's 0.84, lower leverage | |
| Dividends | 100.0% yield, 5-year raise streak, vs CSWC's 10.2% | |
| Momentum (1Y) | +34.0% vs ARCC's +0.4% | |
| Efficiency (ROA) | Efficiency ratio 0.1% vs SAR's 0.7% |
SAR vs CSWC vs ARCC vs GAIN — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
GAIN leads in 2 of 6 categories
SAR leads 2 • CSWC leads 0 • ARCC leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
GAIN leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
SAR is the larger business by revenue, generating $125.7B annually — 1398.7x GAIN's $90M. GAIN is the more profitable business, keeping 72.7% of every revenue dollar as net income compared to ARCC's 41.3%.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $125.7B | $164M | $3.1B | $90M |
| EBITDAEarnings before interest/tax | $1.1B | $142M | $2.0B | $58M |
| Net IncomeAfter-tax profit | $39M | $103M | $1.1B | $130M |
| Free Cash FlowCash after capex | -$124.6B | -$69M | $1.1B | -$82M |
| Gross MarginGross profit ÷ Revenue | — | +66.5% | +75.7% | +68.6% |
| Operating MarginEBIT ÷ Revenue | -0.1% | +48.5% | +69.7% | +72.7% |
| Net MarginNet income ÷ Revenue | — | +43.1% | +41.3% | +72.7% |
| FCF MarginFCF ÷ Revenue | -70.0% | -132.6% | +36.3% | +126.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +13.1% | +113.3% | -63.9% | +58.1% |
Valuation Metrics
SAR leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 9.3x trailing earnings, GAIN trades at a 43% valuation discount to CSWC's 16.3x P/E. Adjusting for growth (PEG ratio), SAR offers better value at 0.82x vs ARCC's 0.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $363M | $1.4B | $13.6B | $657M |
| Enterprise ValueMkt cap + debt − cash | $271.4B | $2.3B | $28.7B | $1.1B |
| Trailing P/EPrice ÷ TTM EPS | 9.67x | 16.32x | 10.19x | 9.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.00x | 10.06x | 9.92x | 40.66x |
| PEG RatioP/E ÷ EPS growth rate | 0.82x | — | 0.99x | — |
| EV / EBITDAEnterprise value multiple | — | 27.43x | 13.09x | 16.82x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 8.71x | 4.33x | 7.31x |
| Price / BookPrice ÷ Book value/share | — | 1.39x | 0.93x | 1.22x |
| Price / FCFMarket cap ÷ FCF | — | — | 11.92x | 5.77x |
Profitability & Efficiency
GAIN leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
GAIN delivers a 21.9% return on equity — every $100 of shareholder capital generates $22 in annual profit, vs $8 for ARCC. GAIN carries lower financial leverage with a 0.91x debt-to-equity ratio, signaling a more conservative balance sheet compared to ARCC's 1.12x. On the Piotroski fundamental quality scale (0–9), ARCC scores 4/9 vs CSWC's 1/9, reflecting mixed financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +10.3% | +8.1% | +21.9% |
| ROA (TTM)Return on assets | +0.0% | +4.8% | +3.8% | +10.5% |
| ROICReturn on invested capital | -0.1% | +3.5% | +5.7% | +5.3% |
| ROCEReturn on capital employed | -0.3% | +4.6% | +7.5% | +6.8% |
| Piotroski ScoreFundamental quality 0–9 | 1 | 1 | 4 | 4 |
| Debt / EquityFinancial leverage | — | 1.08x | 1.12x | 0.91x |
| Net DebtTotal debt minus cash | $271.0B | $913M | $15.1B | $441M |
| Cash & Equiv.Liquid assets | $22.3B | $43M | $924M | $14M |
| Total DebtShort + long-term debt | $293.3B | $956M | $16.0B | $456M |
| Interest CoverageEBIT ÷ Interest expense | -0.01x | 2.91x | 2.98x | 1.58x |
Total Returns (Dividends Reinvested)
Evenly matched — CSWC and GAIN each lead in 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GAIN five years ago would be worth $17,205 today (with dividends reinvested), compared to $14,249 for SAR. Over the past 12 months, CSWC leads with a +34.0% total return vs ARCC's +0.4%. The 3-year compound annual growth rate (CAGR) favors CSWC at 20.7% vs SAR's 8.6% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | +1.8% | +11.4% | -4.9% | +20.7% |
| 1-Year ReturnPast 12 months | +3.7% | +34.0% | +0.4% | +30.8% |
| 3-Year ReturnCumulative with dividends | +28.0% | +75.8% | +34.2% | +56.5% |
| 5-Year ReturnCumulative with dividends | +42.5% | +51.4% | +47.0% | +72.0% |
| 10-Year ReturnCumulative with dividends | +183.2% | +234.2% | +139.2% | +319.3% |
| CAGR (3Y)Annualised 3-year return | +8.6% | +20.7% | +10.3% | +16.1% |
Risk & Volatility
Evenly matched — CSWC and GAIN each lead in 1 of 2 comparable metrics.
Risk & Volatility
GAIN is the less volatile stock with a 0.53 beta — it tends to amplify market swings less than CSWC's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CSWC currently trades 98.2% from its 52-week high vs ARCC's 81.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.60x | 0.84x | 0.77x | 0.53x |
| 52-Week HighHighest price in past year | $25.64 | $24.43 | $23.42 | $17.14 |
| 52-Week LowLowest price in past year | $20.78 | $19.37 | $17.40 | $13.11 |
| % of 52W HighCurrent price vs 52-week peak | +87.1% | +98.2% | +81.0% | +96.3% |
| RSI (14)Momentum oscillator 0–100 | 46.8 | 63.7 | 56.7 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 125K | 664K | 7.5M | 371K |
Analyst Outlook
SAR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SAR as "Hold", CSWC as "Buy", ARCC as "Buy", GAIN as "Hold". Consensus price targets imply 15.4% upside for ARCC (target: $22) vs -9.1% for GAIN (target: $15). For income investors, SAR offers the higher dividend yield at 100.00% vs ARCC's 2.02%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | — | $22.50 | $21.88 | $15.00 |
| # AnalystsCovering analysts | 11 | 10 | 32 | 7 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +10.2% | +2.0% | +10.0% |
| Dividend StreakConsecutive years of raises | 5 | 3 | 0 | 0 |
| Dividend / ShareAnnual DPS | $3303.17 | $2.45 | $0.38 | $1.66 |
| Buyback YieldShare repurchases ÷ mkt cap | +14.9% | 0.0% | 0.0% | 0.0% |
GAIN leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). SAR leads in 2 (Valuation Metrics, Analyst Outlook). 2 tied.
SAR vs CSWC vs ARCC vs GAIN: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SAR or CSWC or ARCC or GAIN a better buy right now?
For growth investors, Saratoga Investment Corp.
(SAR) is the stronger pick with 1334% revenue growth year-over-year, versus -12. 9% for Gladstone Investment Corporation (GAIN). Gladstone Investment Corporation (GAIN) offers the better valuation at 9. 3x trailing P/E (40. 7x forward), making it the more compelling value choice. Analysts rate Capital Southwest Corporation (CSWC) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SAR or CSWC or ARCC or GAIN?
On trailing P/E, Gladstone Investment Corporation (GAIN) is the cheapest at 9.
3x versus Capital Southwest Corporation at 16. 3x. On forward P/E, Saratoga Investment Corp. is actually cheaper at 9. 0x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Saratoga Investment Corp. wins at 0. 76x versus Ares Capital Corporation's 0. 96x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SAR or CSWC or ARCC or GAIN?
Over the past 5 years, Gladstone Investment Corporation (GAIN) delivered a total return of +72.
0%, compared to +42. 5% for Saratoga Investment Corp. (SAR). Over 10 years, the gap is even starker: GAIN returned +319. 3% versus ARCC's +139. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SAR or CSWC or ARCC or GAIN?
By beta (market sensitivity over 5 years), Gladstone Investment Corporation (GAIN) is the lower-risk stock at 0.
53β versus Capital Southwest Corporation's 0. 84β — meaning CSWC is approximately 56% more volatile than GAIN relative to the S&P 500. On balance sheet safety, Gladstone Investment Corporation (GAIN) carries a lower debt/equity ratio of 91% versus 112% for Ares Capital Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SAR or CSWC or ARCC or GAIN?
By revenue growth (latest reported year), Saratoga Investment Corp.
(SAR) is pulling ahead at 1334% versus -12. 9% for Gladstone Investment Corporation (GAIN). On earnings-per-share growth, the picture is similar: Saratoga Investment Corp. grew EPS 14. 4% year-over-year, compared to -28. 3% for Capital Southwest Corporation. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SAR or CSWC or ARCC or GAIN?
Gladstone Investment Corporation (GAIN) is the more profitable company, earning 72.
7% net margin versus 0. 0% for Saratoga Investment Corp. — meaning it keeps 72. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GAIN leads at 72. 7% versus -0. 1% for SAR. At the gross margin level — before operating expenses — ARCC leads at 75. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SAR or CSWC or ARCC or GAIN more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Saratoga Investment Corp. (SAR) is the more undervalued stock at a PEG of 0. 76x versus Ares Capital Corporation's 0. 96x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Saratoga Investment Corp. (SAR) trades at 9. 0x forward P/E versus 40. 7x for Gladstone Investment Corporation — 31. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ARCC: 15. 4% to $21. 88.
08Which pays a better dividend — SAR or CSWC or ARCC or GAIN?
All stocks in this comparison pay dividends.
Saratoga Investment Corp. (SAR) offers the highest yield at 100. 0%, versus 2. 0% for Ares Capital Corporation (ARCC).
09Is SAR or CSWC or ARCC or GAIN better for a retirement portfolio?
For long-horizon retirement investors, Gladstone Investment Corporation (GAIN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
53), 10. 0% yield, +319. 3% 10Y return). Both have compounded well over 10 years (GAIN: +319. 3%, ARCC: +139. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SAR and CSWC and ARCC and GAIN?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SAR is a small-cap high-growth stock; CSWC is a small-cap deep-value stock; ARCC is a mid-cap high-growth stock; GAIN is a small-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
- Sector: Financial Services
- Market Cap > $100B
- Revenue Growth > 66702%
- Dividend Yield > 40.0%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.